Literature DB >> 17540835

ACCP evidence-based guideline development: a successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations.

Michael H Baumann1, Sandra Zelman Lewis, David Gutterman.   

Abstract

Evidence-based clinical practice guidelines (EBGs) can provide an invaluable distillation of knowledge regarding best practices based on the available evidence. EBGs, providing accurate and useful guidance to best clinical practices, require a rigorous development process. The American College of Chest Physicians (ACCP) has developed a process that embodies transparency, thoroughness, and timeliness, and effective conflict-of-interest management, and it continues to evolve. This process employs a quantitative and rigorous grading of the strength of recommendations and of the quality of evidence that incorporates sensitivity to health-care resource utilization and patient values and preferences. A review of this process is provided to inform the ACCP membership and those wishing to embark on EBG development.

Entities:  

Mesh:

Year:  2007        PMID: 17540835     DOI: 10.1378/chest.07-1271

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  [Therapeutic hypothermia after cardiopulmonary resuscitation - pro and con].

Authors:  Christoph Pechlaner; Michael Joannidis
Journal:  Wien Med Wochenschr       Date:  2008

2.  Canadian Thoracic Society: Presenting a new process for clinical practice guideline production.

Authors:  Samir Gupta; Onil K Bhattacharyya; Melissa C Brouwers; Elizabeth A Estey; Margaret B Harrison; Paul Hernandez; Valerie A Palda; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2009 Nov-Dec       Impact factor: 2.409

3.  UEG framework for the development of high-quality clinical guidelines.

Authors:  Doron Boltin; Doenja Mj Lambregts; Fiona Jones; Matan Siterman; Stefanos Bonovas; Markus Cornberg; Wafaa Khannoussi; Glen Doherty
Journal:  United European Gastroenterol J       Date:  2020-09-02       Impact factor: 4.623

4.  How "should" we write guideline recommendations? Interpretation of deontic terminology in clinical practice guidelines: survey of the health services community.

Authors:  E A Lomotan; G Michel; Z Lin; R N Shiffman
Journal:  Qual Saf Health Care       Date:  2010-08-10

Review 5.  Patient preferences for the treatment of type 2 diabetes: a scoping review.

Authors:  Susan M Joy; Emily Little; Nisa M Maruthur; Tanjala S Purnell; John F P Bridges
Journal:  Pharmacoeconomics       Date:  2013-10       Impact factor: 4.981

Review 6.  Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson
Journal:  Appl Clin Genet       Date:  2015-06-16

7.  Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study.

Authors:  Paul Campsall; Kate Colizza; Sharon Straus; Henry T Stelfox
Journal:  PLoS Med       Date:  2016-05-31       Impact factor: 11.069

Review 8.  Appraisal tools for clinical practice guidelines: a systematic review.

Authors:  Ulrich Siering; Michaela Eikermann; Elke Hausner; Wiebke Hoffmann-Eßer; Edmund A Neugebauer
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

9.  Validation and reliability of a guideline appraisal mini-checklist for daily practice use.

Authors:  Andrea Siebenhofer; Thomas Semlitsch; Thomas Herborn; Ulrich Siering; Ina Kopp; Johannes Hartig
Journal:  BMC Med Res Methodol       Date:  2016-04-02       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.